{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:24:47Z","timestamp":1763036687687},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,5,26]],"date-time":"2012-05-26T00:00:00Z","timestamp":1337990400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Oncol Rep"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1007\/s11912-012-0245-9","type":"journal-article","created":{"date-parts":[[2012,5,25]],"date-time":"2012-05-25T09:18:16Z","timestamp":1337937496000},"page":"395-402","source":"Crossref","is-referenced-by-count":36,"title":["NK\/T-Cell Lymphomas: Pathobiology, Prognosis and Treatment Paradigm"],"prefix":"10.1007","volume":"14","author":[{"given":"Ritsuro","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,5,26]]},"reference":[{"key":"245_CR1","first-page":"285","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"JKC Chan","year":"2008","unstructured":"Chan JKC, Quintanilla-Martinez L, Ferry JA, Peh S-C. Extranodal NK\/T-cell lymphoma, nasal type. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon, France: IARC; 2008. p. 285\u20138."},{"key":"245_CR2","first-page":"276","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"JKC Chan","year":"2008","unstructured":"Chan JKC, Jaffe ES, Ralfkiaer E, Ko Y-H. Aggressive NK-cell leukemia. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon, France: IARC; 2008. p. 276\u20137."},{"key":"245_CR3","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1002\/1097-0142(19951201)76:11<2351::AID-CNCR2820761125>3.0.CO;2-1","volume":"76","author":"M Yamaguchi","year":"1995","unstructured":"Yamaguchi M, Kita K, Miwa H, Nishii K, Oka K, Ohno T, et al. Frequent expression of P-glycoprotein\/MDR1 by nasal T-cell lymphoma cells. Cancer. 1995;76:2351\u20136.","journal-title":"Cancer"},{"key":"245_CR4","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1182\/blood.V93.2.599","volume":"93","author":"M Egashira","year":"1999","unstructured":"Egashira M, Kawamata N, Sugimoto K, Oshimi K. P-glycoprotein expression on normal and abnormally expanded natural killer cells and inhibition of P-glycoprotein function by cyclosporin A and its analogue, PSC833. Blood. 1999;93:599\u2013606.","journal-title":"Blood"},{"key":"245_CR5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1046\/j.1365-2141.2001.02885.x","volume":"114","author":"C Trambas","year":"2001","unstructured":"Trambas C, Wang Z, Cianfriglia M, Woods G. Evidence that natural killer cells express mini P-glycoproteins but not classic 170\u00a0kDa P-glycoprotein. Br J Haematol. 2001;114:177\u201318.","journal-title":"Br J Haematol"},{"key":"245_CR6","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/hon.847","volume":"26","author":"R Suzuki","year":"2008","unstructured":"Suzuki R, Takeuchi K, Ohshima K, Nakamura S. Extranodal NK\/T-cell lymphoma: diagnosis and treatment cues. Hematol Oncol. 2008;26:66\u201372.","journal-title":"Hematol Oncol"},{"key":"245_CR7","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1007\/s12185-010-0720-8","volume":"92","author":"SJ Kim","year":"2010","unstructured":"Kim SJ, Kim WS. Treatment of localized extranodal NK\/T cell lymphoma, nasal type. Int J Hematol. 2010;92:690\u20136.","journal-title":"Int J Hematol"},{"key":"245_CR8","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s12185-010-0726-2","volume":"92","author":"R Suzuki","year":"2010","unstructured":"Suzuki R. Treatment of advanced extranodal NK\/T cell lymphoma, nasal-type and aggressive NK-cell leukemia. Int J Hematol. 2010;92:697\u2013701.","journal-title":"Int J Hematol"},{"key":"245_CR9","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0167-5699(88)91317-5","volume":"9","author":"T Hercend","year":"1998","unstructured":"Hercend T, Schmidt RE. Characteristics and uses of natural killer cells. Immunol Today. 1998;9:291\u20133.","journal-title":"Immunol Today"},{"key":"245_CR10","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1182\/blood.V76.12.2421.2421","volume":"76","author":"MJ Robertson","year":"1990","unstructured":"Robertson MJ, Ritz J. Biology and clinical relevance of human natural killer cells. Blood. 1990;76:2421\u201338.","journal-title":"Blood"},{"key":"245_CR11","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1084\/jem.180.2.569","volume":"180","author":"MJ Sanchez","year":"1994","unstructured":"Sanchez MJ, Muench MO, Roncarolo MG, Lanier LL, Phillips JH. Identification of a common T\/natural killer cell progenitor in human fetal thymus. J Exp Med. 1994;180:569\u201376.","journal-title":"J Exp Med"},{"key":"245_CR12","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1182\/blood.V85.12.3538.bloodjournal85123538","volume":"85","author":"A Shibuya","year":"1995","unstructured":"Shibuya A, Nagayoshi K, Nakamura K, Nakauchi H. Lymphokine requirement for the generation of natural killer cells from CD34\u00fe hematopoietic progenitor cells. Blood. 1995;85:3538\u201346.","journal-title":"Blood"},{"key":"245_CR13","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1002\/1097-0142(19821201)50:11<2336::AID-CNCR2820501120>3.0.CO;2-C","volume":"50","author":"Y Ishii","year":"1982","unstructured":"Ishii Y, Yamanaka N, Ogawa K, Yoshida Y, Takami T, Matsuura A, et al. Nasal T-cell lymphoma as a type of so-called \"lethal midline granuloma\". Cancer. 1982;50:2336\u201344.","journal-title":"Cancer"},{"key":"245_CR14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00000478-199601000-00012","volume":"20","author":"ES Jaffe","year":"1996","unstructured":"Jaffe ES, Chan JKC, Su I-J, Frizzera G, Mori S, Feller AC, et al. Report of the workshop on nasal and related extranodal angiocentric T\/natural killer cell lymphomas. Definitions, differential diagnosis, and epidemiology. Am J Surg Pathol. 1996;20:103\u201311.","journal-title":"Am J Surg Pathol"},{"key":"245_CR15","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1182\/blood.V83.8.2255.2255","volume":"83","author":"J Suzumiya","year":"1994","unstructured":"Suzumiya J, Takeshita M, Kimura N, Kikuchi M, Uchida T, Hisano S, et al. Expression of adult and fetal natural killer cell markers in sinonasal lymphomas. Blood. 1994;83:2255\u201360.","journal-title":"Blood"},{"key":"245_CR16","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1182\/blood.V87.4.1466.bloodjournal8741466","volume":"87","author":"J-F Emile","year":"1996","unstructured":"Emile J-F, Boulland M-L, Haioun C, Kanavaros P, Petrella T, Delfau-Larue MH, et al. CD5- CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas. Blood. 1996;87:1466\u201373.","journal-title":"Blood"},{"key":"245_CR17","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1046\/j.1365-2559.1997.2880887.x","volume":"31","author":"K Ohshima","year":"1997","unstructured":"Ohshima K, Suzumiya J, Shimazaki K, Kato A, Tanaka T, Kanda M, et al. Nasal T\/NK cell lymphomas commonly express perforin and Fas ligand: important mediators of tissue damage. Histopathology. 1997;31:444\u201350.","journal-title":"Histopathology"},{"key":"245_CR18","first-page":"699","volume":"149","author":"N Mori","year":"1996","unstructured":"Mori N, Yatabe Y, Oka K, Kinoshita T, Kobayashi T, Ono T, et al. Expression of perforin in nasal lymphoma. Am J Pathol. 1996;149:699\u2013705.","journal-title":"Am J Pathol"},{"key":"245_CR19","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1200\/JCO.1999.17.12.3835","volume":"17","author":"NL Harris","year":"1999","unstructured":"Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting - Airlie House, Virginia, November 1997. J Clin Oncol. 1999;17:3835\u201349.","journal-title":"J Clin Oncol"},{"key":"245_CR20","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1200\/JCO.1998.16.1.70","volume":"16","author":"MMC Cheung","year":"1998","unstructured":"Cheung MMC, Chan JKC, Lau WH, Foo W, Chan PT, Ng CS, Ngan RK. Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients. J Clin Oncol. 1998;16:70\u20137.","journal-title":"J Clin Oncol"},{"key":"245_CR21","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/hed.20015","volume":"26","author":"GE Kim","year":"2004","unstructured":"Kim GE, Koom WS, Yang WI, Lee SW, Keum KC, Lee CG, Suh CO, Hahn JS, Roh JK, Kim JH. Clinical relevance of three subtypes of primary sinonasal lymphoma characterized by immunophenotypic analysis. Head Neck. 2004;26:584\u201393.","journal-title":"Head Neck"},{"key":"245_CR22","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0140-6736(90)90002-M","volume":"335","author":"Y Harabuchi","year":"1990","unstructured":"Harabuchi Y, Yamanaka N, Kataura A, Imai S, Kinoshita T, Mizuno F, Osato T. Epstein\u2013Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet. 1990;335:128\u201330.","journal-title":"Lancet"},{"key":"245_CR23","first-page":"108","volume":"71","author":"K Kawa","year":"2000","unstructured":"Kawa K. Epstein\u2013Barr virus\u2013associated diseases in humans. Int J Hematol. 2000;71:108\u201317.","journal-title":"Int J Hematol"},{"key":"245_CR24","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1046\/j.1365-2141.1997.3223139.x","volume":"98","author":"KF Wong","year":"1997","unstructured":"Wong KF, Chan JK, Kwong YL. Identification of del(6)(q21q25) as a recurring chromosomal abnormality in putative NK cell lymphoma\/leukaemia. Br J Haematol. 1997;98:922\u20136.","journal-title":"Br J Haematol"},{"key":"245_CR25","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1046\/j.1365-2141.1997.752711.x","volume":"97","author":"HF Tien","year":"1997","unstructured":"Tien HF, Su IJ, Tang JL, Liu MC, Lee FY, Chen YC, Chuang SM. Clonal chromosomal abnormalities as direct evidence for clonality in nasal T\/natural killer cell lymphomas. Br J Haematol. 1997;97:621\u20135.","journal-title":"Br J Haematol"},{"key":"245_CR26","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/sj.leu.2403262","volume":"18","author":"R Suzuki","year":"2004","unstructured":"Suzuki R, Suzumiya J, Nakamura S, Aoki S, Notoya A, Ozaki S, et al. Aggressive natural killer (NK)-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells. Leukemia. 2004;18:763\u201370.","journal-title":"Leukemia"},{"key":"245_CR27","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/gcc.20245","volume":"44","author":"Y Nakashima","year":"2005","unstructured":"Nakashima Y, Tagawa H, Suzuki R, Karnan S, Karube K, Ohshima K, Muta K, Nawata H, Morishima Y, Nakamura S, Seto M. Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma\/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal NK\/T-cell lymphoma, nasal type. Genes Chromosomes Cancer. 2005;44:247\u201355.","journal-title":"Genes Chromosomes Cancer"},{"key":"245_CR28","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/leu.2009.3","volume":"23","author":"J Iqbal","year":"2009","unstructured":"Iqbal J, Kucuk C, Deleeuw RJ, Srivastava G, Tam W, Geng H, Klinkebiel D, Christman JK, Patel K, Cao K, Shen L, Dybkaer K, Tsui IF, Ali H, Shimizu N, Au WY, Lam WL, Chan WC. Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies. Leukemia. 2009;23:1139\u201351.","journal-title":"Leukemia"},{"key":"245_CR29","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1182\/blood-2011-04-346890","volume":"118","author":"K Karube","year":"2011","unstructured":"Karube K, Nakagawa M, Tsuzuki S, Takeuchi I, Honma K, Nakashima Y, Shimizu N, Ko YH, Morishima Y, Ohshima K, Nakamura S, Seto M. Identification of FOXO3 and PRDM1 as tumor-suppressor gene candidates in NK-cell neoplasms by genomic and functional analyses. Blood. 2011;118:3195\u2013204.","journal-title":"Blood"},{"key":"245_CR30","doi-asserted-by":"crossref","first-page":"20119","DOI":"10.1073\/pnas.1115128108","volume":"108","author":"C K\u00fc\u00e7\u00fck","year":"2011","unstructured":"K\u00fc\u00e7\u00fck C, Iqbal J, Hu X, Gaulard P, De Leval L, Srivastava G, Au WY, McKeithan TW, Chan WC. PRDM1 is a tumor suppressor gene in natural killer cell malignancies. Proc Natl Acad Sci USA. 2011;108:20119\u201324.","journal-title":"Proc Natl Acad Sci USA"},{"key":"245_CR31","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1084\/jem.20052204","volume":"203","author":"L Pasqualucci","year":"2006","unstructured":"Pasqualucci L, Compagno M, Houldsworth J, Monti S, Grunn A, Nandula SV, Aster JC, Murty VV, Shipp MA, Dalla-Favera R. Inactivation of the PRDM1\/BLIMP1 gene in diffuse large B cell lymphoma. J Exp Med. 2006;203:311\u20137.","journal-title":"J Exp Med"},{"key":"245_CR32","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.1182\/blood-2005-09-3778","volume":"107","author":"W Tam","year":"2006","unstructured":"Tam W, Gomez M, Chadburn A, Lee JW, Chan WC, Knowles DM. Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas. Blood. 2006;107:4090\u2013100.","journal-title":"Blood"},{"key":"245_CR33","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1349-7006.2001.tb01059.x","volume":"92","author":"S Sakajiri","year":"2001","unstructured":"Sakajiri S, Kawamata N, Egashira M, Mori K, Oshimi K. Molecular analysis of tumor suppressor genes, Rb, p53, p16INK4A, p15INK4B and p14ARF in natural killer cell neoplasms. Jpn J Cancer Res. 2001;92:1048\u201356.","journal-title":"Jpn J Cancer Res"},{"key":"245_CR34","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0002-9440(10)63061-1","volume":"159","author":"L Quintanilla-Martinez","year":"2001","unstructured":"Quintanilla-Martinez L, Kremer M, Keller G, Nathrath M, Gamboa-Dominguez A, Meneses A, Luna-Contreras L, Cabras A, Hoefler H, Mohar A, Fend F. p53 Mutations in nasal natural killer\/T-cell lymphoma from Mexico: association with large cell morphology and advanced disease. Am J Pathol. 2001;159:2095\u2013105.","journal-title":"Am J Pathol"},{"key":"245_CR35","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1093\/annonc\/mdp418","volume":"21","author":"R Suzuki","year":"2010","unstructured":"Suzuki R, Suzumiya J, Yamaguchi M, Nakamura S, Kameoka J, Kojima H, Abe M, Kinoshita T, Yoshino T, Iwatsuki K, Kagami Y, Tsuzuki T, Kurokawa M, Ito K, Kawa K, Oshimi K. Prognostic factors for mature natural killer (NK)-cell neoplasms: aggressive NK-cell leukemia and extranodal NK-cell lymphoma, nasal-type. Ann Oncol. 2010;21:1032\u201340.","journal-title":"Ann Oncol"},{"key":"245_CR36","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1182\/blood-2003-05-1401","volume":"103","author":"CS Chim","year":"2004","unstructured":"Chim CS, Ma SY, Au WY, Choy C, Lie AK, Liang R, et al. Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the international prognostic index. Blood. 2004;103:216\u201321.","journal-title":"Blood"},{"key":"245_CR37","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1182\/blood-2005-05-2056","volume":"106","author":"TM Kim","year":"2005","unstructured":"Kim TM, Park YH, Lee SY, Kim JH, Kim DW, Im SA, et al. Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage IE\/IIE extranodal NK\/T-cell lymphoma, nasal type. Blood. 2005;106:3785\u201390.","journal-title":"Blood"},{"key":"245_CR38","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1200\/JCO.2005.04.1384","volume":"24","author":"J Lee","year":"2006","unstructured":"Lee J, Suh C, Park YH, Ko YH, Bang SM, Lee JH, et al. Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study. J Clin Oncol. 2006;24:612\u20138.","journal-title":"J Clin Oncol"},{"key":"245_CR39","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/(SICI)1097-0142(19980801)83:3<449::AID-CNCR13>3.0.CO;2-W","volume":"83","author":"YX Li","year":"1998","unstructured":"Li YX, Coucke PA, Li JY, Gu DZ, Liu XF, Zhou LQ, Mirimanoff RO, Yu ZH, Huang YR. Primary non-Hodgkin's lymphoma of the nasal cavity: prognostic significance of paranasal extension and the role of radiotherapy and chemotherapy. Cancer. 1998;83:449\u201356.","journal-title":"Cancer"},{"key":"245_CR40","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/cncr.11908","volume":"100","author":"CC Li","year":"2004","unstructured":"Li CC, Tien HF, Tang JL, Yao M, Chen YC, Su IJ, et al. Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer\/T-cell or T-cell lymphoma. Cancer. 2004;100:366\u201375.","journal-title":"Cancer"},{"key":"245_CR41","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/modpathol.3800157","volume":"17","author":"SB Ng","year":"2004","unstructured":"Ng SB, Lai KW, Murugaya S, Lee KM, Loong SL, Fook-Chong S, Tao M, Sng I. Nasal-type extranodal natural killer\/T-cell lymphomas: a clinicopathologic and genotypic study of 42 cases in Singapore. Mod Pathol. 2004;17:1097\u2013107.","journal-title":"Mod Pathol"},{"key":"245_CR42","unstructured":"Ahn HK, Suh C, Chuang SS, Suzumiya J, Ko YH, Kim SJ, Huh JR, Yoon DH, Oh SY, Kim JS, Lee SI, Park KW, Hsieh PP, Nakamura S, Yoshino T, Ito K, Nagatani T, Oshimi K, Suzuki R, Kim WS. Extranodal natural killer\/T cell lymphoma from skin or soft tissue: suggestion of treatment from multinational retrospective analysis. Ann Oncol (in press)"},{"key":"245_CR43","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1182\/blood-2008-10-185256","volume":"113","author":"WY Au","year":"2009","unstructured":"Au WY, Weisenburger DD, Intragumtornchai T, Nakamura S, Kim WS, Sng I, Vose J, Armitage JO, Liang R. Clinical differences between nasal and extranasal NK\/T-cell lymphoma: a study of 136 cases from the International Peripheral T-cell Lymphoma Project. Blood. 2009;113:3931\u20137.","journal-title":"Blood"},{"key":"245_CR44","doi-asserted-by":"crossref","first-page":"6260","DOI":"10.1182\/blood-2009-03-211011","volume":"113","author":"R Suzuki","year":"2009","unstructured":"Suzuki R, Suzumiya J, Oshimi K. Differences between nasal and extra-nasal NK\/T-cell lymphoma. Blood. 2009;113:6260\u20131.","journal-title":"Blood"},{"key":"245_CR45","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","volume":"117","author":"E Campo","year":"2011","unstructured":"Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood. 2011;117:5019\u201332.","journal-title":"Blood"},{"key":"245_CR46","first-page":"1856","volume":"7","author":"YM Dennis Lo","year":"2001","unstructured":"Dennis Lo YM, Chan WY, Ng EKW, Chan LYS, Lai PBS, Tam JS, Sydney Chung SC. Circulating Epstein\u2013Barr virus DNA in the serum of patients with gastric carcinoma. Clin Cancer Res. 2001;7:1856\u20139.","journal-title":"Clin Cancer Res"},{"key":"245_CR47","first-page":"2028","volume":"63","author":"KCA Chan","year":"2003","unstructured":"Chan KCA, Zhang J, Chan ATC, Lei KIK, Leung S-F, Chan LYS, Chow KCK, Lo YMD. Molecular characterization of circulating EBV DNA in the plasma of nasopharyngeal carcinoma and lymphoma patients. Cancer Res. 2003;63:2028\u201332.","journal-title":"Cancer Res"},{"key":"245_CR48","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1182\/blood-2003-12-4197","volume":"104","author":"WY Au","year":"2004","unstructured":"Au WY, Pang A, Choy C, Chim CS, Kwong YL. Quantification of circulating Epstein\u2013Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients. Blood. 2004;104:243\u20139.","journal-title":"Blood"},{"key":"245_CR49","doi-asserted-by":"crossref","first-page":"6018","DOI":"10.1182\/blood-2011-05-354142","volume":"118","author":"R Suzuki","year":"2011","unstructured":"\u2022 Suzuki R, Yamaguchi M, Izutsu K, Yamamoto G, Takada K, Harabuchi Y, Isobe Y, Gomyo H, Koike T, Okamoto M, Hyo R, Suzumiya J, Nakamura S, Kawa K, Oshimi K. Prospective measurement of Epstein\u2013Barr virus-DNA in plasma and peripheral blood mononuclear cells of extranodal NK\/T-cell lymphoma, nasal type. Blood. 2011;118:6018\u201322. Plasma EBV-DNA can predict tumor burden, response to treatment and prognosis of patients with ENKL.","journal-title":"Blood"},{"key":"245_CR50","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/rmv.582","volume":"18","author":"H Kimura","year":"2008","unstructured":"Kimura H, Ito Y, Suzuki R, Nishiyama Y. Measuring Epstein\u2013Barr virus (EBV) load: its significance and application in each EBV-associated disease. Rev Med Virol. 2008;18:305\u201319.","journal-title":"Rev Med Virol"},{"key":"245_CR51","doi-asserted-by":"crossref","first-page":"2873a","DOI":"10.1182\/blood.V116.21.2873.2873","volume":"116","author":"R Suzuki","year":"2009","unstructured":"Suzuki R, Kimura H, Kwong YL, Maeda Y, Hashimoto C, Kim WS, Suh C, Izutsu K, Ishida F, Ito Y, Yamaguchi M, Suzumiya J, Hyo R, Nakamura S, Oshimi K. Pretreatment EBV-DNA copy number is predictive for response to SMILE chemotherapy for newly-diagnosed stage IV, relapsed or refractory extranodal NK\/T-cell lymphoma, nasal type: results of NKTSG phase II study. Blood. 2009;116:2873a [Abstract #2873].","journal-title":"Blood"},{"key":"245_CR52","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1200\/JCO.2000.18.1.54","volume":"18","author":"GE Kim","year":"2000","unstructured":"Kim GE, Cho JH, Yang WI, Chung EJ, Suh CO, Park KR, et al. Angiocentric lymphoma of the head and neck: patterns of systemic failure after radiation treatment. J Clin Oncol. 2000;18:54\u201363.","journal-title":"J Clin Oncol"},{"key":"245_CR53","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/annonc\/mdh143","volume":"15","author":"JY You","year":"2004","unstructured":"You JY, Chi KH, Yang MH, Chen CC, Ho CH, Chau WK, et al. Radiation therapy versus chemotherapy as initial treatment for localized nasal natural killer (NK)\/T-cell lymphoma: a single institute survey in Taiwan. Ann Oncol. 2004;15:618\u201325.","journal-title":"Ann Oncol"},{"key":"245_CR54","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1080\/10428190600565651","volume":"47","author":"SJ Kim","year":"2006","unstructured":"Kim SJ, Kim BS, Choi CW, Seo HY, Seol HR, Sung HJ, et al. Treatment outcome of front-line systemic chemotherapy for localized extranodal NK\/T cell lymphoma in nasal and upper aerodigestive tract. Leuk Lymphoma. 2006;47:1265\u201373.","journal-title":"Leuk Lymphoma"},{"key":"245_CR55","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1080\/10428190601059795","volume":"48","author":"B Wang","year":"2007","unstructured":"Wang B, Lu JJ, Ma X, Guo Y, Lu H, Hong X, et al. Combined chemotherapy and external beam radiation for stage IE and IIE natural killer T-cell lymphoma of nasal cavity. Leuk Lymphoma. 2007;48:396\u2013402.","journal-title":"Leuk Lymphoma"},{"key":"245_CR56","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1200\/JCO.2005.03.2573","volume":"24","author":"YX Li","year":"2006","unstructured":"Li YX, Yao B, Jin J, Wang WH, Liu YP, Song YW, et al. Radiotherapy as primary treatment for stage IE and IIE nasal natural killer\/T-cell lymphoma. J Clin Oncol. 2006;24:181\u20139.","journal-title":"J Clin Oncol"},{"key":"245_CR57","doi-asserted-by":"crossref","first-page":"5594","DOI":"10.1200\/JCO.2009.23.8295","volume":"27","author":"M Yamaguchi","year":"2009","unstructured":"Yamaguchi M, Tobinai K, Oguchi M, Ishizuka N, Kobayashi Y, Isobe Y, et al. Phase I\/II study of concurrent chemoradiotherapy for localized nasal natural killer\/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211. J Clin Oncol. 2009;27:5594\u2013600.","journal-title":"J Clin Oncol"},{"key":"245_CR58","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.1200\/JCO.2009.23.8592","volume":"27","author":"SJ Kim","year":"2009","unstructured":"Kim SJ, Kim K, Kim BS, Kim CY, Suh C, Huh J, et al. Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK\/T-cell lymphoma: Consortium for Improving Survival of Lymphoma Study. J Clin Oncol. 2009;27:6027\u201332.","journal-title":"J Clin Oncol"},{"key":"245_CR59","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1093\/annonc\/mdg458","volume":"14","author":"WY Au","year":"2003","unstructured":"Au WY, Lie AK, Liang R, Kwong YL, Yau CC, Cheung MM, Ngan KC, Lau WH, Wong KH, Yiu HY, Cheng HC, Au KH, Chan JK. Autologous stem cell transplantation for nasal NK\/T-cell lymphoma: a progress report on its value. Ann Oncol. 2003;14:1673\u20136.","journal-title":"Ann Oncol"},{"key":"245_CR60","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/sj.bmt.1705244","volume":"37","author":"R Suzuki","year":"2006","unstructured":"Suzuki R, Suzumiya J, Nakamura S, Kagami Y, Kameoka J, Sakai C, et al. Hematopoietic stem cell transplantation for natural killer-cell lineage neoplasms. Bone Marrow Transplant. 2006;37:425\u201331.","journal-title":"Bone Marrow Transplant"},{"key":"245_CR61","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/sj.bmt.1705349","volume":"37","author":"HJ Kim","year":"2006","unstructured":"Kim HJ, Bang SM, Lee J, Kwon HC, Suh C, Kim HJ, et al. High-dose chemotherapy with autologous stem cell transplantation in extranodal NK\/T-cell lymphoma: a retrospective comparison with non-transplantation cases. Bone Marrow Transplant. 2006;37:819\u201324.","journal-title":"Bone Marrow Transplant"},{"key":"245_CR62","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.bbmt.2008.09.014","volume":"14","author":"J Lee","year":"2008","unstructured":"Lee J, Au WY, Park MJ, Suzumiya J, Nakamura S, Kameoka J, et al. Autologous hematopoietic stem cell transplantation in extranodal natural killer\/T cell lymphoma: a multinational, multicenter, matched controlled study. Biol Blood Marrow Transplant. 2008;14:1356\u201364.","journal-title":"Biol Blood Marrow Transplant"},{"key":"245_CR63","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3960\/jslrt.45.51","volume":"45","author":"R Suzuki","year":"2005","unstructured":"Suzuki R. Leukemia and lymphoma of natural killer cells. J Clin Exp Hematop. 2005;45:51\u201370.","journal-title":"J Clin Exp Hematop"},{"key":"245_CR64","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1200\/JCO.2011.35.6287","volume":"29","author":"M Yamaguchi","year":"2011","unstructured":"\u2022\u2022 Yamaguchi M, Kwong YL, Kim WS, Maeda Y, Hashimoto C, Suh C, Izutsu K, Ishida F, Isobe Y, Sueoka E, Suzumiya J, Kodama T, Kimura H, Hyo R, Nakamura S, Oshimi K, Suzuki R. Phase II study of SMILE chemotherapy for newly-diagnosed stage IV, relapsed or refractory extranodal NK\/T-cell lymphoma, nasal type: The NK-cell Tumor Study Group (NKTSG) study. J Clin Oncol. 2011;29:4410\u20136. SMILE chemotherapy improves ORR, PFS and OS in patients with disseminated\/relapsed\/refractory ENKL.","journal-title":"J Clin Oncol"},{"key":"245_CR65","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF02983387","volume":"78","author":"W Yong","year":"2003","unstructured":"Yong W, Zheng W, Zhang Y, Zhu J, Wei Y, Zhu D, et al. L-asparaginase-based regimen in the treatment of refractory midline nasal\/nasal-type T\/NK-cell lymphoma. Int J Hematol. 2003;78:163\u20137.","journal-title":"Int J Hematol"},{"key":"245_CR66","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/annonc\/mdn542","volume":"20","author":"A Jaccard","year":"2009","unstructured":"Jaccard A, Petit B, Girault S, Suarez F, Gressin R, Zini JM, Coiteux V, Larroche C, Devidas A, Thi\u00e9blemont C, Gaulard P, Marin B, Gachard N, Bordessoule D, Hermine O. L-Asparaginase-based treatment of 15 western patients with extranodal NK\/T-cell lymphoma and leukemia and a review of the literature. Ann Oncol. 2009;20:110\u20136.","journal-title":"Ann Oncol"},{"key":"245_CR67","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1182\/blood-2010-09-307454","volume":"117","author":"A Jaccard","year":"2011","unstructured":"Jaccard A, Gachard N, Marin B, et al. Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK\/T-cell lymphoma, a phase II study. Blood. 2011;117:1834\u20139.","journal-title":"Blood"},{"key":"245_CR68","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-2141.2005.05651.x","volume":"130","author":"N Murashige","year":"2005","unstructured":"Murashige N, Kami M, Kishi Y, Kim S-W, Takeuchi M, Matsue K, et al. Allogeneic haematopoietic stem cell transplantation as a promising treatment for natural killer-cell neoplasms. Br J Haematol. 2005;130:561\u20137.","journal-title":"Br J Haematol"},{"key":"245_CR69","doi-asserted-by":"crossref","first-page":"503a","DOI":"10.1182\/blood.V118.21.503.503","volume":"118","author":"R Suzuki","year":"2011","unstructured":"Suzuki R, Kako S, Hyo R, Izutsu K, Ito T, Shinagawa K, Endo T, Sakamaki H, Suzumiya J. Comparison of autologous and allogeneic hematopoietic stem cell transplantation for extranodal NK\/T-cell lymphoma, nasal-type: Analysis of The Japan Society for Hematopoietic Cell Transplantation (JSHCT) Lymphoma Working Group. Blood. 2011;118:503a [Abstract #503].","journal-title":"Blood"}],"container-title":["Current Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-012-0245-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11912-012-0245-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-012-0245-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T02:59:30Z","timestamp":1594177170000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11912-012-0245-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,26]]},"references-count":69,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["245"],"URL":"https:\/\/doi.org\/10.1007\/s11912-012-0245-9","relation":{},"ISSN":["1523-3790","1534-6269"],"issn-type":[{"value":"1523-3790","type":"print"},{"value":"1534-6269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,26]]}}}